CHANGES OF INTESTINAL MICROBIOME IN MULTIPLE SCLEROSIS ARE ASSOCIATED WITH IMMUNE SHIFT AND PSYCHOEMOTIONAL DISORDERS
- Authors: Abdurasulova IN1, Matsulevich AV1, Tarasova EA1, Kudryavtsev IV1, Nikiforova IG2, Serebryakova MK1, Miroshnichenko MI1, Ivashkova EV2, Tatarinov AE1, Ilves AG2, Ermolenko EI1, Bisaga GN3, Stolyarov ID2, Klimenko VM1
-
Affiliations:
- Institute of experimental medicine, Saint Petersburg
- N.P. Bechtereva Institute of the Human Brain of the RAS, Saint Petersburg
- Almazov National Medical Research Center, Saint Petersburg
- Issue: Vol 19, No 1S (2019)
- Pages: 51-54
- Section: Articles
- Published: 15.12.2019
- URL: https://journals.eco-vector.com/MAJ/article/view/19321
- ID: 19321
Cite item
Full Text
Abstract
Full Text
Introduction. Recently, the brain-gut-microbiome axis has become a major research area at the neuroscience and neuroimmunology. The study of intestinal microbes influence immunity, brain, and behavior will offer a more complete understanding of neuro-immune interactions and human psychology [1]. Multiple sclerosis (MS) is a disease in which immune system dysfunction and nervous system disruption are observed. Following, patients have psycho-emotional disorders and disturbances of the gastrointestinal tract [2, 3]. Changes in the gut microbiome in MS are shown [4, 5], however, it has not been investigated as it is associated with immune and psycho-emotional disorders. The aim of the study was to assess the changes in the intestinal microbiome in MS patients and to analyze the associations of bacterial level with various peripheral blood Th cell subsets as well as with psycho-emotional disorders. Material and methods. The study involved 126 patients (82 female; 44 male) with duration of MS 12.2 ± 0.9 years. The control group (CG) consisted of 69 healthy volunteers. Characteristics of the patients are shown in the table. Metagenomic analysis of gut microbiome (16rRNA) was determined using the Illumina/Solexa sequencing method. The quantitative content of microorganisms was determined by the method of cultivation and qPCR, as described previously [3]. Th phenotypes in peripheral blood were determined by flow cytometry [6]. Psycho-emotional state was assessed as previously described [2], additionally used the hospital anxiety and depression scale (HADS). Results and discussion. In the gut microbiome of MS patients, the proportion of Bacteroides was decreased compared to CG (28% vs. 50%; p = 0,023), especially Prevotellaceae (3% vs. 21%) and the shares of Firmicutes (57% vs. 36% in CG) and Actinobacteria (4% vs. 1% in CG) were increased. The proportions of class Bacilli (Streptococcaceae) and Clostridia representatines (Ruminococcaceaea and Christensenellaceae) included in the phylum Firmicutes were increased in MS patients. This data is consistent with the one of the other authors [4, 5]. Archaea (Methanobacteriaceae) were detected only in MS, especially in patients with early disease onset and with a higher disease severity (EDSS > 3.5). In Enterobacteriaceae (phylum Proteobacteria) symbiotic species were replaced by opportunistic species, that correlated with the severity of the disease. The increasing level of Bifidobacteria spp. and Enterococcus spp. has also been noted in cases of more severity of MS. The certain bacterial species was associated with the content of several Th subsets. The frequency of Th1 cells at different stages of differentiation positively correlated with the levels of Lactobacillus spp. and Akkermansia muciniphila and negatively - with Enterococcus spp., Prevotella spp., Enterobacter spp. The levels of Lactobacillus spp., Enterococcus spp. and Enterobacter spp. also correlated with the relative numbers of “classical” or Th17/Th22 and DP Th17 cells, however, these dependencies were opposite with Th1. Bifidobacterium spp. level also correlated with DP Th17 content too. These data suggest that the changes in the microbiome could influence immune cell subsets frequencies and these changes could result in the prevalence of pathogenic Th17 subtypes in MS patients. In addition, psycho-emotional disorders were detected in patients with MS (Table 1). The increased level of reactive anxiety (RA) was observed in majority (83.5%) of MS patients. Mild or moderate asthenia (50.5 vs. 38.5 for CG) was noted in 48% of MS patients (AS). Mild depression of situational genesis was detected in 17% of patients with MS (DL), and subclinical depression was diagnosed in 21.7% (HADS). Psycho-emotional disorders in MS patients positively correlated with the disease severity and were not related to gender. Analysis of the relationship of these disorders with changes in the intestinal microbiome showed that depression in patients positively correlated with the Bifidobacteria spp. level and negatively with A. muciniphila level, anxiety - with levels of Escherichia coli and Prevotella spp., and asthenia with levels of atypical E. coli and Sutterella spp. More pronounced changes in micriome and connection of the bacterial level with psycho-emotional disorders were observed in patients with a more severity of the disease. Thus, the revealed changes in gut microbiome in MS and their connection with immune shift and psycho-emotional disorders demonstrate that the intestinal microbiota may be the target for influence in correcting immune and psycho-emotional disorders. Preliminary studies have shown that probiotics, in particular, Enterococcus faecium L-3, can be used for this [2, 3]. Acknowledgments. Center for collective use of scientific equipment of the Research Institute of Agricultural Microbiology (E.E. Andronov and A.G. Pinaev) for help in microbiom sequencing.About the authors
I N Abdurasulova
Institute of experimental medicine, Saint Petersburg
A V Matsulevich
Institute of experimental medicine, Saint Petersburg
E A Tarasova
Institute of experimental medicine, Saint Petersburg
I V Kudryavtsev
Institute of experimental medicine, Saint Petersburg
I G Nikiforova
N.P. Bechtereva Institute of the Human Brain of the RAS, Saint Petersburg
M K Serebryakova
Institute of experimental medicine, Saint Petersburg
M I Miroshnichenko
Institute of experimental medicine, Saint Petersburg
E V Ivashkova
N.P. Bechtereva Institute of the Human Brain of the RAS, Saint Petersburg
A E Tatarinov
Institute of experimental medicine, Saint Petersburg
A G Ilves
N.P. Bechtereva Institute of the Human Brain of the RAS, Saint Petersburg
E I Ermolenko
Institute of experimental medicine, Saint Petersburg
G N Bisaga
Almazov National Medical Research Center, Saint Petersburg
I D Stolyarov
N.P. Bechtereva Institute of the Human Brain of the RAS, Saint Petersburg
V M Klimenko
Institute of experimental medicine, Saint Petersburg
References
- Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012;13(10):701-712.
- Matsulevich AV, Abdurasulova IN, Tarasova EA, et al. Effect of course application of Enterococcus faecium L-3 on the psychoemotinal state of patients with multiple sclerosis. Med. Acad. Zh. 2017;17(3):38-46. (In Russ.).
- Abdurasulova IN, Tarasova EA, Ermolenko EI, et al. Multiple sclerosis is associated with the altered quantitative and qualitative composition of intestinal microbiota. Med. Acad. Zh. 2015;15(3):55-67. (In Russ.).
- Miyake S, Kim S, Suda W, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS One. 2015;10(9):e0137429.
- Jangi S, Gandhi R, Cox LM, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7:12015.
- Kudryavtsev IV, Ilves AG, Borisov AG, et al. CCR6-positive T-helper subsets from peripheral blood in multiple sclerosis. Cytokines and inflammation. 2016:15(2):166-172. (In Russ.).
- Abdurasulova IN, Matsulevich AV, Tarasova EA, et al. Enterococcus faecium L3 and glatiramer acetate ameliorate of experimental allergic encephalomyelitis (EAE) in rats by affecting different populations of immune cells. Beneficial microbes. 2016;7(5):719-729.